Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if MNKD is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
35 top institutions tracked
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 16 days ago
Red flags: 0
258 filers reported a long position in MNKD for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BlackRock, Inc. | $136.9M | 32.1M | +12.4% |
| Rubric Capital Management LP | $76.7M | 18M | +397.2% |
| STATE STREET CORP | $68.9M | 16.2M | -13.4% |
| VANGUARD CAPITAL MANAGEMENT LLC | $56.1M | 13.2M | +2.2% |
| GEODE CAPITAL MANAGEMENT, LLC | $33.9M | 7.9M | +5.9% |
| WELLINGTON MANAGEMENT GROUP LLP | $33.4M | 7.8M | +138.9% |
| Frazier Life Sciences Management, L.P. | $28.1M | 6.6M | +11.9% |
| Deep Track Capital, LP | $25.6M | 6M | New |
| 180 WEALTH ADVISORS, LLC | $21.1M | 5M | +15.6% |
| FMR LLC | $17.5M | 4.1M | +17.8% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.